Global and Japan Tacrolimus Market Insights, Forecast to 2027

Publisher Name :
Date: 25-Aug-2021
No. of pages: 161
Inquire Before Buying

Tacrolimus market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Tacrolimus market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the Tacrolimus market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

- Tacrolimus Capsules

- Tacrolimus Ointment

- Tacrolimus Injection

Segment by Application

- Hospitals

- Clinics

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- GSK

- Abbott

- Roche Pharma

- Novartis

- Mylan

- Squibb

- Astellas

- Aarti Group

- Takeda

- Huapont Pharma

- Senju Pharmaceutical

- Guike Pharmaceutical

- Tecoland

- Sandoz

- ScinoPharm

- RPG Life Science

- Suzhou Pharmaceutical Technology

- Accura Pharmaceuticals

- Fujisawa Pharmaceutical

- Sichuan Med-Shine Pharmaceutical

- Sinopharm Chuankang Pharmaceutical

- Yamanouchi Pharmaceutical

- Zhongmei Huadong Pharmaceutical

- Hisun Pharmaceutical

Global and Japan Tacrolimus Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Tacrolimus Product Introduction
1.2 Market by Type
1.2.1 Global Tacrolimus Market Size Growth Rate by Type
1.2.2 Tacrolimus Capsules
1.2.3 Tacrolimus Ointment
1.2.4 Tacrolimus Injection
1.3 Market by Application
1.3.1 Global Tacrolimus Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tacrolimus Market Size, Estimates and Forecasts
2.1.1 Global Tacrolimus Revenue 2016-2027
2.1.2 Global Tacrolimus Sales 2016-2027
2.2 Global Tacrolimus, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Tacrolimus Historical Market Size by Region (2016-2021)
2.3.1 Global Tacrolimus Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Tacrolimus Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Tacrolimus Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Tacrolimus Sales Forecast by Region (2022-2027)
2.4.2 Global Tacrolimus Revenue Forecast by Region (2022-2027)
3 Global Tacrolimus Competitor Landscape by Players
3.1 Global Top Tacrolimus Manufacturers by Sales
3.1.1 Global Tacrolimus Sales by Manufacturer (2016-2021)
3.1.2 Global Tacrolimus Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Tacrolimus Manufacturers by Revenue
3.2.1 Key Tacrolimus Manufacturers Covered: Ranking by Revenue
3.2.2 Global Tacrolimus Revenue by Manufacturers (2016-2021)
3.2.3 Global Tacrolimus Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Tacrolimus Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Tacrolimus Revenue in 2020
3.2.6 Global Tacrolimus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Tacrolimus Price by Manufacturers
3.4 Global Tacrolimus Manufacturing Base Distribution, Product Types
3.4.1 Tacrolimus Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tacrolimus Product Type
3.4.3 Date of International Manufacturers Enter into Tacrolimus Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Tacrolimus Market Size by Type (2016-2021)
4.1.1 Global Tacrolimus Sales by Type (2016-2021)
4.1.2 Global Tacrolimus Revenue by Type (2016-2021)
4.1.3 Tacrolimus Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Tacrolimus Market Size Forecast by Type (2022-2027)
4.2.1 Global Tacrolimus Sales Forecast by Type (2022-2027)
4.2.2 Global Tacrolimus Revenue Forecast by Type (2022-2027)
4.2.3 Tacrolimus Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Tacrolimus Market Size by Application (2016-2021)
5.1.1 Global Tacrolimus Sales by Application (2016-2021)
5.1.2 Global Tacrolimus Revenue by Application (2016-2021)
5.1.3 Tacrolimus Price by Application (2016-2021)
5.2 Tacrolimus Market Size Forecast by Application (2022-2027)
5.2.1 Global Tacrolimus Sales Forecast by Application (2022-2027)
5.2.2 Global Tacrolimus Revenue Forecast by Application (2022-2027)
5.2.3 Global Tacrolimus Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Tacrolimus Market Size YoY Growth 2016-2027
6.1.1 Japan Tacrolimus Sales YoY Growth 2016-2027
6.1.2 Japan Tacrolimus Revenue YoY Growth 2016-2027
6.1.3 Japan Tacrolimus Market Share in Global Market 2016-2027
6.2 Japan Tacrolimus Market Size by Players (International and Local Players)
6.2.1 Japan Top Tacrolimus Players by Sales (2016-2021)
6.2.2 Japan Top Tacrolimus Players by Revenue (2016-2021)
6.3 Japan Tacrolimus Historic Market Review by Type (2016-2021)
6.3.1 Japan Tacrolimus Sales Market Share by Type (2016-2021)
6.3.2 Japan Tacrolimus Revenue Market Share by Type (2016-2021)
6.3.3 Japan Tacrolimus Price by Type (2016-2021)
6.4 Japan Tacrolimus Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Tacrolimus Sales Forecast by Type (2022-2027)
6.4.2 Japan Tacrolimus Revenue Forecast by Type (2022-2027)
6.4.3 Japan Tacrolimus Price Forecast by Type (2022-2027)
6.5 Japan Tacrolimus Historic Market Review by Application (2016-2021)
6.5.1 Japan Tacrolimus Sales Market Share by Application (2016-2021)
6.5.2 Japan Tacrolimus Revenue Market Share by Application (2016-2021)
6.5.3 Japan Tacrolimus Price by Application (2016-2021)
6.6 Japan Tacrolimus Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Tacrolimus Sales Forecast by Application (2022-2027)
6.6.2 Japan Tacrolimus Revenue Forecast by Application (2022-2027)
6.6.3 Japan Tacrolimus Price Forecast by Application (2022-2027)
7 North America
7.1 North America Tacrolimus Market Size YoY Growth 2016-2027
7.2 North America Tacrolimus Market Facts & Figures by Country
7.2.1 North America Tacrolimus Sales by Country (2016-2021)
7.2.2 North America Tacrolimus Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Tacrolimus Market Size YoY Growth 2016-2027
8.2 Asia Pacific Tacrolimus Market Facts & Figures by Region
8.2.1 Asia Pacific Tacrolimus Sales by Region (2016-2021)
8.2.2 Asia Pacific Tacrolimus Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Tacrolimus Market Size YoY Growth 2016-2027
9.2 Europe Tacrolimus Market Facts & Figures by Country
9.2.1 Europe Tacrolimus Sales by Country (2016-2021)
9.2.2 Europe Tacrolimus Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Tacrolimus Market Size YoY Growth 2016-2027
10.2 Latin America Tacrolimus Market Facts & Figures by Country
10.2.1 Latin America Tacrolimus Sales by Country (2016-2021)
10.2.2 Latin America Tacrolimus Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Tacrolimus Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Tacrolimus Market Facts & Figures by Country
11.2.1 Middle East and Africa Tacrolimus Sales by Country (2016-2021)
11.2.2 Middle East and Africa Tacrolimus Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Description and Business Overview
12.1.3 GSK Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Tacrolimus Products Offered
12.1.5 GSK Recent Development
12.2 Abbott
12.2.1 Abbott Corporation Information
12.2.2 Abbott Description and Business Overview
12.2.3 Abbott Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Abbott Tacrolimus Products Offered
12.2.5 Abbott Recent Development
12.3 Roche Pharma
12.3.1 Roche Pharma Corporation Information
12.3.2 Roche Pharma Description and Business Overview
12.3.3 Roche Pharma Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Roche Pharma Tacrolimus Products Offered
12.3.5 Roche Pharma Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Tacrolimus Products Offered
12.4.5 Novartis Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Description and Business Overview
12.5.3 Mylan Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mylan Tacrolimus Products Offered
12.5.5 Mylan Recent Development
12.6 Squibb
12.6.1 Squibb Corporation Information
12.6.2 Squibb Description and Business Overview
12.6.3 Squibb Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Squibb Tacrolimus Products Offered
12.6.5 Squibb Recent Development
12.7 Astellas
12.7.1 Astellas Corporation Information
12.7.2 Astellas Description and Business Overview
12.7.3 Astellas Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Astellas Tacrolimus Products Offered
12.7.5 Astellas Recent Development
12.8 Aarti Group
12.8.1 Aarti Group Corporation Information
12.8.2 Aarti Group Description and Business Overview
12.8.3 Aarti Group Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Aarti Group Tacrolimus Products Offered
12.8.5 Aarti Group Recent Development
12.9 Takeda
12.9.1 Takeda Corporation Information
12.9.2 Takeda Description and Business Overview
12.9.3 Takeda Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Takeda Tacrolimus Products Offered
12.9.5 Takeda Recent Development
12.10 Huapont Pharma
12.10.1 Huapont Pharma Corporation Information
12.10.2 Huapont Pharma Description and Business Overview
12.10.3 Huapont Pharma Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Huapont Pharma Tacrolimus Products Offered
12.10.5 Huapont Pharma Recent Development
12.11 GSK
12.11.1 GSK Corporation Information
12.11.2 GSK Description and Business Overview
12.11.3 GSK Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GSK Tacrolimus Products Offered
12.11.5 GSK Recent Development
12.12 Guike Pharmaceutical
12.12.1 Guike Pharmaceutical Corporation Information
12.12.2 Guike Pharmaceutical Description and Business Overview
12.12.3 Guike Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Guike Pharmaceutical Products Offered
12.12.5 Guike Pharmaceutical Recent Development
12.13 Tecoland
12.13.1 Tecoland Corporation Information
12.13.2 Tecoland Description and Business Overview
12.13.3 Tecoland Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Tecoland Products Offered
12.13.5 Tecoland Recent Development
12.14 Sandoz
12.14.1 Sandoz Corporation Information
12.14.2 Sandoz Description and Business Overview
12.14.3 Sandoz Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Sandoz Products Offered
12.14.5 Sandoz Recent Development
12.15 ScinoPharm
12.15.1 ScinoPharm Corporation Information
12.15.2 ScinoPharm Description and Business Overview
12.15.3 ScinoPharm Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.15.4 ScinoPharm Products Offered
12.15.5 ScinoPharm Recent Development
12.16 RPG Life Science
12.16.1 RPG Life Science Corporation Information
12.16.2 RPG Life Science Description and Business Overview
12.16.3 RPG Life Science Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.16.4 RPG Life Science Products Offered
12.16.5 RPG Life Science Recent Development
12.17 Suzhou Pharmaceutical Technology
12.17.1 Suzhou Pharmaceutical Technology Corporation Information
12.17.2 Suzhou Pharmaceutical Technology Description and Business Overview
12.17.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Suzhou Pharmaceutical Technology Products Offered
12.17.5 Suzhou Pharmaceutical Technology Recent Development
12.18 Accura Pharmaceuticals
12.18.1 Accura Pharmaceuticals Corporation Information
12.18.2 Accura Pharmaceuticals Description and Business Overview
12.18.3 Accura Pharmaceuticals Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Accura Pharmaceuticals Products Offered
12.18.5 Accura Pharmaceuticals Recent Development
12.19 Fujisawa Pharmaceutical
12.19.1 Fujisawa Pharmaceutical Corporation Information
12.19.2 Fujisawa Pharmaceutical Description and Business Overview
12.19.3 Fujisawa Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Fujisawa Pharmaceutical Products Offered
12.19.5 Fujisawa Pharmaceutical Recent Development
12.20 Sichuan Med-Shine Pharmaceutical
12.20.1 Sichuan Med-Shine Pharmaceutical Corporation Information
12.20.2 Sichuan Med-Shine Pharmaceutical Description and Business Overview
12.20.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Sichuan Med-Shine Pharmaceutical Products Offered
12.20.5 Sichuan Med-Shine Pharmaceutical Recent Development
12.21 Sinopharm Chuankang Pharmaceutical
12.21.1 Sinopharm Chuankang Pharmaceutical Corporation Information
12.21.2 Sinopharm Chuankang Pharmaceutical Description and Business Overview
12.21.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Sinopharm Chuankang Pharmaceutical Products Offered
12.21.5 Sinopharm Chuankang Pharmaceutical Recent Development
12.22 Yamanouchi Pharmaceutical
12.22.1 Yamanouchi Pharmaceutical Corporation Information
12.22.2 Yamanouchi Pharmaceutical Description and Business Overview
12.22.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Yamanouchi Pharmaceutical Products Offered
12.22.5 Yamanouchi Pharmaceutical Recent Development
12.23 Zhongmei Huadong Pharmaceutical
12.23.1 Zhongmei Huadong Pharmaceutical Corporation Information
12.23.2 Zhongmei Huadong Pharmaceutical Description and Business Overview
12.23.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Zhongmei Huadong Pharmaceutical Products Offered
12.23.5 Zhongmei Huadong Pharmaceutical Recent Development
12.24 Hisun Pharmaceutical
12.24.1 Hisun Pharmaceutical Corporation Information
12.24.2 Hisun Pharmaceutical Description and Business Overview
12.24.3 Hisun Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Hisun Pharmaceutical Products Offered
12.24.5 Hisun Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Tacrolimus Industry Trends
13.2 Tacrolimus Market Drivers
13.3 Tacrolimus Market Challenges
13.4 Tacrolimus Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tacrolimus Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Tacrolimus Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tacrolimus Capsules
Table 3. Major Manufacturers of Tacrolimus Ointment
Table 4. Major Manufacturers of Tacrolimus Injection
Table 5. Global Tacrolimus Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 6. Global Tacrolimus Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Tacrolimus Sales by Regions (2016-2021) & (K MT)
Table 8. Global Tacrolimus Sales Market Share by Regions (2016-2021)
Table 9. Global Tacrolimus Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Tacrolimus Sales Forecast by Region (2022-2027) & (K MT)
Table 11. Global Tacrolimus Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Tacrolimus Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Tacrolimus Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Tacrolimus Sales by Manufacturers (2016-2021) (K MT)
Table 15. Global Tacrolimus Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Tacrolimus Manufacturers by Revenue (US$ Million) in 2020
Table 17. Tacrolimus Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Tacrolimus Revenue Share by Manufacturers (2016-2021)
Table 19. Global Tacrolimus Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Tacrolimus by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tacrolimus as of 2020)
Table 21. Key Manufacturers Tacrolimus Price (2016-2021) (USD/MT)
Table 22. Tacrolimus Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Tacrolimus Product Type
Table 24. Date of International Manufacturers Enter into Tacrolimus Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Tacrolimus Sales by Type (2016-2021) (K MT)
Table 27. Global Tacrolimus Sales Share by Type (2016-2021)
Table 28. Global Tacrolimus Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Tacrolimus Revenue Share by Type (2016-2021)
Table 30. Tacrolimus Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 31. Global Tacrolimus Sales Forecast by Type (2022-2027) & (K MT)
Table 32. Global Tacrolimus Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Tacrolimus Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Tacrolimus Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Tacrolimus Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 36. Global Tacrolimus Sales by Application (2016-2021) (K MT)
Table 37. Global Tacrolimus Sales Share by Application (2016-2021)
Table 38. Global Tacrolimus Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Tacrolimus Revenue Share by Application (2016-2021)
Table 40. Tacrolimus Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 41. Global Tacrolimus Sales Forecast by Application (2022-2027) & (K MT)
Table 42. Global Tacrolimus Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Tacrolimus Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Tacrolimus Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Tacrolimus Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 46. Japan Tacrolimus Sales (K MT) of Key Companies (2016-2021)
Table 47. Japan Tacrolimus Sales Share by Company (2016-2021)
Table 48. Japan Tacrolimus Revenue (US$ Million) by Company (2016-2021)
Table 49. Japan Tacrolimus Revenue Share by Company (2016-2021)
Table 50. Japan Tacrolimus Sales (K MT) by Type (2016-2021)
Table 51. Japan Tacrolimus Sales Share by Type (2016-2021)
Table 52. Japan Tacrolimus Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. Japan Tacrolimus Price (USD/MT) by Type (2016-2021)
Table 54. Japan Tacrolimus Sales (K MT) by Type (2022-2027)
Table 55. Japan Tacrolimus Sales Share by Type (2022-2027)
Table 56. Japan Tacrolimus Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. Japan Tacrolimus Revenue Share by Type (2022-2027)
Table 58. Japan Tacrolimus Price (USD/MT) by Type (2022-2027)
Table 59. Japan Tacrolimus Sales (K MT) by Application (2016-2021)
Table 60. Japan Tacrolimus Sales Share by Application (2016-2021)
Table 61. Japan Tacrolimus Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. Japan Tacrolimus Price (USD/MT) by Application (2016-2021)
Table 63. Japan Tacrolimus Sales (K MT) by Application (2022-2027)
Table 64. Japan Tacrolimus Sales Share by Application (2022-2027)
Table 65. Japan Tacrolimus Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. Japan Tacrolimus Revenue Share by Application (2022-2027)
Table 67. Japan Tacrolimus Price (USD/MT) by Application (2022-2027)
Table 68. North America Tacrolimus Sales by Country (2016-2021) & (K MT)
Table 69. North America Tacrolimus Sales Market Share by Country (2016-2021)
Table 70. North America Tacrolimus Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Tacrolimus Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Tacrolimus Sales by Region (2016-2021) & (K MT)
Table 73. Asia Pacific Tacrolimus Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Tacrolimus Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Tacrolimus Revenue Market Share by Region (2016-2021)
Table 76. Europe Tacrolimus Sales by Country (2016-2021) & (K MT)
Table 77. Europe Tacrolimus Sales Market Share by Country (2016-2021)
Table 78. Europe Tacrolimus Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Tacrolimus Revenue Market Share by Country (2016-2021)
Table 80. Latin America Tacrolimus Sales by Country (2016-2021) & (K MT)
Table 81. Latin America Tacrolimus Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Tacrolimus Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Tacrolimus Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Tacrolimus Sales by Country (2016-2021) & (K MT)
Table 85. Middle East and Africa Tacrolimus Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Tacrolimus Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Tacrolimus Revenue Market Share by Country (2016-2021)
Table 88. GSK Corporation Information
Table 89. GSK Description and Business Overview
Table 90. GSK Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. GSK Tacrolimus Product
Table 92. GSK Recent Development
Table 93. Abbott Corporation Information
Table 94. Abbott Description and Business Overview
Table 95. Abbott Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Abbott Product
Table 97. Abbott Recent Development
Table 98. Roche Pharma Corporation Information
Table 99. Roche Pharma Description and Business Overview
Table 100. Roche Pharma Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Roche Pharma Product
Table 102. Roche Pharma Recent Development
Table 103. Novartis Corporation Information
Table 104. Novartis Description and Business Overview
Table 105. Novartis Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Novartis Product
Table 107. Novartis Recent Development
Table 108. Mylan Corporation Information
Table 109. Mylan Description and Business Overview
Table 110. Mylan Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. Mylan Product
Table 112. Mylan Recent Development
Table 113. Squibb Corporation Information
Table 114. Squibb Description and Business Overview
Table 115. Squibb Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 116. Squibb Product
Table 117. Squibb Recent Development
Table 118. Astellas Corporation Information
Table 119. Astellas Description and Business Overview
Table 120. Astellas Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 121. Astellas Product
Table 122. Astellas Recent Development
Table 123. Aarti Group Corporation Information
Table 124. Aarti Group Description and Business Overview
Table 125. Aarti Group Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 126. Aarti Group Product
Table 127. Aarti Group Recent Development
Table 128. Takeda Corporation Information
Table 129. Takeda Description and Business Overview
Table 130. Takeda Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 131. Takeda Product
Table 132. Takeda Recent Development
Table 133. Huapont Pharma Corporation Information
Table 134. Huapont Pharma Description and Business Overview
Table 135. Huapont Pharma Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 136. Huapont Pharma Product
Table 137. Huapont Pharma Recent Development
Table 138. Senju Pharmaceutical Corporation Information
Table 139. Senju Pharmaceutical Description and Business Overview
Table 140. Senju Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 141. Senju Pharmaceutical Product
Table 142. Senju Pharmaceutical Recent Development
Table 143. Guike Pharmaceutical Corporation Information
Table 144. Guike Pharmaceutical Description and Business Overview
Table 145. Guike Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 146. Guike Pharmaceutical Product
Table 147. Guike Pharmaceutical Recent Development
Table 148. Tecoland Corporation Information
Table 149. Tecoland Description and Business Overview
Table 150. Tecoland Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 151. Tecoland Product
Table 152. Tecoland Recent Development
Table 153. Sandoz Corporation Information
Table 154. Sandoz Description and Business Overview
Table 155. Sandoz Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 156. Sandoz Product
Table 157. Sandoz Recent Development
Table 158. ScinoPharm Corporation Information
Table 159. ScinoPharm Description and Business Overview
Table 160. ScinoPharm Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 161. ScinoPharm Product
Table 162. ScinoPharm Recent Development
Table 163. RPG Life Science Corporation Information
Table 164. RPG Life Science Description and Business Overview
Table 165. RPG Life Science Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 166. RPG Life Science Product
Table 167. RPG Life Science Recent Development
Table 168. Suzhou Pharmaceutical Technology Corporation Information
Table 169. Suzhou Pharmaceutical Technology Description and Business Overview
Table 170. Suzhou Pharmaceutical Technology Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 171. Suzhou Pharmaceutical Technology Product
Table 172. Suzhou Pharmaceutical Technology Recent Development
Table 173. Accura Pharmaceuticals Corporation Information
Table 174. Accura Pharmaceuticals Description and Business Overview
Table 175. Accura Pharmaceuticals Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 176. Accura Pharmaceuticals Product
Table 177. Accura Pharmaceuticals Recent Development
Table 178. Fujisawa Pharmaceutical Corporation Information
Table 179. Fujisawa Pharmaceutical Description and Business Overview
Table 180. Fujisawa Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 181. Fujisawa Pharmaceutical Product
Table 182. Fujisawa Pharmaceutical Recent Development
Table 183. Sichuan Med-Shine Pharmaceutical Corporation Information
Table 184. Sichuan Med-Shine Pharmaceutical Description and Business Overview
Table 185. Sichuan Med-Shine Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 186. Sichuan Med-Shine Pharmaceutical Product
Table 187. Sichuan Med-Shine Pharmaceutical Recent Development
Table 188. Sinopharm Chuankang Pharmaceutical Corporation Information
Table 189. Sinopharm Chuankang Pharmaceutical Description and Business Overview
Table 190. Sinopharm Chuankang Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 191. Sinopharm Chuankang Pharmaceutical Product
Table 192. Sinopharm Chuankang Pharmaceutical Recent Development
Table 193. Yamanouchi Pharmaceutical Corporation Information
Table 194. Yamanouchi Pharmaceutical Description and Business Overview
Table 195. Yamanouchi Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 196. Yamanouchi Pharmaceutical Product
Table 197. Yamanouchi Pharmaceutical Recent Development
Table 198. Zhongmei Huadong Pharmaceutical Corporation Information
Table 199. Zhongmei Huadong Pharmaceutical Description and Business Overview
Table 200. Zhongmei Huadong Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 201. Zhongmei Huadong Pharmaceutical Product
Table 202. Zhongmei Huadong Pharmaceutical Recent Development
Table 203. Hisun Pharmaceutical Corporation Information
Table 204. Hisun Pharmaceutical Description and Business Overview
Table 205. Hisun Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 206. Hisun Pharmaceutical Product
Table 207. Hisun Pharmaceutical Recent Development
Table 208. Tacrolimus Market Trends
Table 209. Tacrolimus Market Drivers
Table 210. Tacrolimus Market Challenges
Table 211. Tacrolimus Market Restraints
Table 212. Tacrolimus Customers List
Table 213. Tacrolimus Distributors List
Table 214. Research Programs/Design for This Report
Table 215. Key Data Information from Secondary Sources
Table 216. Key Data Information from Primary Sources
List of Figures
Figure 1. Tacrolimus Product Picture
Figure 2. Global Tacrolimus Sales Market Share by Type in 2020 & 2027
Figure 3. Tacrolimus Capsules Product Picture
Figure 4. Tacrolimus Ointment Product Picture
Figure 5. Tacrolimus Injection Product Picture
Figure 6. Global Tacrolimus Sales Market Share by Application in 2020 & 2027
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Other
Figure 10. Tacrolimus Report Years Considered
Figure 11. Global Tacrolimus Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Tacrolimus Market Size 2016-2027 (US$ Million)
Figure 13. Global Tacrolimus Sales 2016-2027 (K MT)
Figure 14. Global Tacrolimus Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Tacrolimus Sales Market Share by Region (2016-2021)
Figure 16. Global Tacrolimus Sales Market Share by Region in 2020
Figure 17. Global Tacrolimus Revenue Market Share by Region (2016-2021)
Figure 18. Gl
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs